Want to join the conversation?
$HALO 2Q15 Q&A: Fye of JPMorgan asked about starting PD-1 combo study. Helen replied we articulated as part of our strategy a number of quarters ago that both chemo and immunotherapy are going to play important role in non-small cell lung cancer, so planned & developed separate teams to be driving these programs. So they are not in any way related.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th